LIFT-AD trial did not meet primary endpoint of GST and key secondary endpoints of cognition (ADAS-Cog11) and function ...

Athira Pharma (ATHA) saw its shares tailspin 81% after its lead candidate fosgonimeton failed the Phase II/III LIFT-AD ...

Alzheimer disease research is yielding breakthroughs with blood tests and brain scans that can enhance early diagnosis, while ...

His team has developed an ultrasensitive test to measure a protein called ... and PET scan for diagnosis. A class of acetylcholinesterase inhibitor drugs prevents an enzyme from breaking down ...

Sage may also act as an acetylcholinesterase (AChE) inhibitor. This enzyme breaks down ... Always do a patch test before trying a new essential oil. Peppermint oil is a popular aromatherapy.

Both test scores will then be analysed and tracked over time ... However, some treatments are available that help alleviate some of the symptoms. One of these is Acetylcholinesterase inhibitors which ...

It enrolled 312 patients who were not taking standard acetylcholinesterase (AChE) inhibitors. While the trial’s main goal ... was to determine changes in the Global Statistical Test (GST), which ...

This offers the potential for targeted drug therapy of clinically symptomatic visual hallucinations in patients with schizophrenia using acetylcholinesterase inhibition. Methods: A systematic ...

Immune checkpoint inhibitors (ICIs) are a class of immunotherapy that have revolutionized the treatment of cancer. However, ...